These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 23682096

  • 1. Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
    Hwang JS, Lee HS, Chung WY, Han HS, Jin DK, Kim HS, Ko CW, Lee BC, Lee DY, Lee KH, Shin JH, Suh BK, Yoo HW, Ji HJ, Lee JH, Bae YJ, Kim DH, Yang SW.
    Eur J Endocrinol; 2013 Aug; 169(2):179-85. PubMed ID: 23682096
    [Abstract] [Full Text] [Related]

  • 2. 24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.
    Khadilkar V, Radjuk KA, Bolshova E, Khadgawat R, El Kholy M, Desai M, Peterkova V, Mericq V, Kratzsch J, Siepl EC, Martin D, Lopez P, Ji HJ, Bae YJ, Lee JH, Saenger PH.
    J Clin Endocrinol Metab; 2014 Jan; 99(1):126-32. PubMed ID: 24170106
    [Abstract] [Full Text] [Related]

  • 3. Once-Weekly Administration of Sustained-Release Growth Hormone in Korean Prepubertal Children with Idiopathic Short Stature: A Randomized, Controlled Phase II Study.
    Hwang JS, Lee HS, Lee KH, Yoo HW, Lee DY, Suh BK, Ko CW, Chung WY, Jin DK, Shin CH, Han HS, Han S, Kim HS.
    Horm Res Paediatr; 2018 Jan; 90(1):54-63. PubMed ID: 29925064
    [Abstract] [Full Text] [Related]

  • 4. Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).
    Péter F, Bidlingmaier M, Savoy C, Ji HJ, Saenger PH.
    J Clin Endocrinol Metab; 2012 Feb; 97(2):400-7. PubMed ID: 22162481
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.
    Peter F, Savoy C, Ji HJ, Juhasz M, Bidlingmaier M, Saenger P.
    Eur J Endocrinol; 2009 Mar; 160(3):349-55. PubMed ID: 19074465
    [Abstract] [Full Text] [Related]

  • 7. Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.
    Bidlingmaier M, Kim J, Savoy C, Kim MJ, Ebrecht N, de la Motte S, Strasburger CJ.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2926-30. PubMed ID: 16720652
    [Abstract] [Full Text] [Related]

  • 8. Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.
    Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ.
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1718-26. PubMed ID: 21411551
    [Abstract] [Full Text] [Related]

  • 9. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA, MS316 Study Group.
    Horm Res Paediatr; 2015 Jun; 83(4):268-79. PubMed ID: 25765099
    [Abstract] [Full Text] [Related]

  • 10. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.
    Moore WV, Nguyen HJ, Kletter GB, Miller BS, Rogers D, Ng D, Moore JA, Humphriss E, Cleland JL, Bright GM.
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1091-7. PubMed ID: 26672637
    [Abstract] [Full Text] [Related]

  • 11. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.
    Romer T, Peter F, Saenger P, Starzyk J, Koehler B, Korman E, Walczak M, Wasik R, Ginalska-Malinowska M, Solyom E, Berghout A.
    J Endocrinol Invest; 2007 Oct; 30(7):578-89. PubMed ID: 17848841
    [Abstract] [Full Text] [Related]

  • 13. 12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.
    Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ.
    Pituitary; 2013 Sep; 16(3):311-8. PubMed ID: 22915288
    [Abstract] [Full Text] [Related]

  • 14. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
    Sävendahl L, Battelino T, Brod M, Højby Rasmussen M, Horikawa R, Juul RV, Saenger P, REAL 3 study group.
    J Clin Endocrinol Metab; 2020 Apr 01; 105(4):e1847-61. PubMed ID: 31917835
    [Abstract] [Full Text] [Related]

  • 15. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L, Chen ZH, Liu D, Cheng YG, Luo XP.
    Drug Des Devel Ther; 2016 Apr 01; 10():13-21. PubMed ID: 26719670
    [Abstract] [Full Text] [Related]

  • 16. Long-Acting C-Terminal Peptide-Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children.
    Zelinska N, Iotova V, Skorodok J, Malievsky O, Peterkova V, Samsonova L, Rosenfeld RG, Zadik Z, Jaron-Mendelson M, Koren R, Amitzi L, Raduk D, Hershkovitz O, Hart G.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1578-1587. PubMed ID: 28323965
    [Abstract] [Full Text] [Related]

  • 17. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 May 01; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 18. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency.
    Reiter EO, Attie KM, Moshang T, Silverman BL, Kemp SF, Neuwirth RB, Ford KM, Saenger P, Genentech, Inc.-Alkermes, Inc. Collaborative Study Group.
    J Clin Endocrinol Metab; 2001 Oct 01; 86(10):4700-6. PubMed ID: 11600528
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.